JP2013515002A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515002A5
JP2013515002A5 JP2012544917A JP2012544917A JP2013515002A5 JP 2013515002 A5 JP2013515002 A5 JP 2013515002A5 JP 2012544917 A JP2012544917 A JP 2012544917A JP 2012544917 A JP2012544917 A JP 2012544917A JP 2013515002 A5 JP2013515002 A5 JP 2013515002A5
Authority
JP
Japan
Prior art keywords
composition
dimethylamino
composition according
ketoprofen
dodecyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012544917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515002A (ja
JP6200648B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061130 external-priority patent/WO2011075688A1/en
Publication of JP2013515002A publication Critical patent/JP2013515002A/ja
Publication of JP2013515002A5 publication Critical patent/JP2013515002A5/ja
Application granted granted Critical
Publication of JP6200648B2 publication Critical patent/JP6200648B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012544917A 2009-12-18 2010-12-17 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物 Expired - Fee Related JP6200648B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28795309P 2009-12-18 2009-12-18
US61/287,953 2009-12-18
PCT/US2010/061130 WO2011075688A1 (en) 2009-12-18 2010-12-17 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016028621A Division JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013515002A JP2013515002A (ja) 2013-05-02
JP2013515002A5 true JP2013515002A5 (cg-RX-API-DMAC7.html) 2017-07-20
JP6200648B2 JP6200648B2 (ja) 2017-09-20

Family

ID=44167727

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012544917A Expired - Fee Related JP6200648B2 (ja) 2009-12-18 2010-12-17 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
JP2016028621A Pending JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016028621A Pending JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Country Status (9)

Country Link
US (2) US20130109674A1 (cg-RX-API-DMAC7.html)
EP (1) EP2512240B1 (cg-RX-API-DMAC7.html)
JP (2) JP6200648B2 (cg-RX-API-DMAC7.html)
AU (2) AU2010330747B2 (cg-RX-API-DMAC7.html)
CA (1) CA2784824A1 (cg-RX-API-DMAC7.html)
DK (1) DK2512240T3 (cg-RX-API-DMAC7.html)
ES (1) ES2677352T3 (cg-RX-API-DMAC7.html)
IL (2) IL220464A (cg-RX-API-DMAC7.html)
WO (1) WO2011075688A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9629920B2 (en) 2009-12-18 2017-04-25 Exodos Life Sciences Limited Partnership Methods and compositions for stable liquid drug formulations
US9192637B1 (en) * 2011-09-23 2015-11-24 Natural Fibers Corporation Milkweed seed oil administered to animals
WO2013074517A1 (en) * 2011-11-14 2013-05-23 Roswell Park Cancer Institute Kinase protein binding inhibitors
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
JP2016503410A (ja) * 2012-11-09 2016-02-04 スリーイー セラピューティクス コーポレイション３Ｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｘ線造影剤組成物およびそれを使用して炎症関連症状を治療する方法
EP2964257B1 (en) * 2013-03-08 2024-10-09 Research Institute at Nationwide Children's Hospital Transcutaneous dosage formulation
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9011934B2 (en) 2013-06-14 2015-04-21 SatisPharma, LLC Multi-purpose anti-itch treatment
EP3096721A4 (en) * 2014-01-22 2017-10-18 Marcio Marc Abreu Devices configured to provide treatment at an abreu brain thermal tunnel
US9452178B1 (en) 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations
WO2016089893A1 (en) * 2014-12-01 2016-06-09 Achelios Therapeutics Inc. Methods and compositions for treating migraine and conditions associated with pain
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
BR112017020307B1 (pt) 2015-03-26 2023-11-07 Jacqueline M. Iversen Usos de uma combinação de naproxeno e fexofenadina
WO2017024214A1 (en) * 2015-08-05 2017-02-09 Synergistic Therapeutics, Llc Topical analgesis loton
US20190105260A1 (en) * 2016-03-22 2019-04-11 The Regents Of The University Of California Compositions and methods to promote wound healing
JP7024248B2 (ja) * 2016-09-01 2022-02-24 大正製薬株式会社 固形製剤
CA3063870A1 (en) * 2017-05-15 2018-11-22 Biochemics, Inc. Transdermally-delivered combination drug therapy for pain
JP7673337B2 (ja) * 2019-11-07 2025-05-09 アリナミン製薬株式会社 医薬組成物
EP3900715A1 (en) * 2020-04-21 2021-10-27 Dompe' Farmaceutici S.P.A. Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medical use
EP3900716A1 (en) * 2020-04-21 2021-10-27 Dompe' Farmaceutici S.P.A. Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use
WO2023073457A1 (en) * 2021-10-30 2023-05-04 Mousavi Mirzaei Seyed Mohammad A topical pain-relief medicine for relieving headache

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5169637A (en) 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
CA1237671A (en) 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US4975282A (en) 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US5409704A (en) 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
US5023087A (en) 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
IE60901B1 (en) 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5032582A (en) 1987-02-27 1991-07-16 Liposome Technology, Inc. Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
US4994213A (en) 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US5194266A (en) 1989-08-08 1993-03-16 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition and method
US5356633A (en) 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
CA2108288C (en) 1991-04-19 2003-09-16 Jill P. Adler-Moore Liposomal cyclosporin formulation and process for the preparation thereof
GR1002207B (en) 1992-08-06 1996-03-27 Johnson & Johnson Consumer Skin care compositions containing imidazoles.
US5552155A (en) 1992-12-04 1996-09-03 The Liposome Company, Inc. Fusogenic lipsomes and methods for making and using same
AU5938996A (en) 1995-06-07 1996-12-30 Nexstar Pharmaceuticals, Inc. Method for encapsulating pharmaceutical materials
US6387407B1 (en) * 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
ATE334689T1 (de) * 1995-11-13 2006-08-15 Univ Northwest Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
US6083996A (en) 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6139861A (en) * 1999-01-14 2000-10-31 Friedman; Mark Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
US6118020A (en) * 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6642243B1 (en) * 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
US20020143047A1 (en) * 2001-01-05 2002-10-03 Galer Bradley S. Methods for treating indomethacin responsive headaches
US20070112052A9 (en) * 2001-01-05 2007-05-17 Larry Caldwell Methods and compositions for treating headache pain with topical NSAID compositions
DE60228294D1 (en) * 2001-06-05 2008-09-25 Ronald Aung-Din Topische migränetherapie
US20040138239A1 (en) * 2001-08-23 2004-07-15 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
WO2003077847A2 (en) * 2002-03-12 2003-09-25 Merck & Co., Inc. Substituted amides
WO2004075832A2 (en) * 2003-02-27 2004-09-10 Lucas John M Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
US7357950B2 (en) * 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US20050095277A1 (en) * 2003-06-25 2005-05-05 Binnur Ozturk Neuropathy cream
US20050019354A1 (en) * 2003-07-23 2005-01-27 Perricone Nicholas V. Topical benfotiamine treatments
AU2005210668A1 (en) * 2004-01-30 2005-08-18 Angiotech International Ag Compositions and methods for treating contracture
AU2005235308B2 (en) * 2004-04-19 2011-12-01 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US7749515B2 (en) * 2005-02-01 2010-07-06 Allergan, Inc. Targeted delivery of botulinum toxin to the sphenopalatine ganglion
WO2006122123A2 (en) * 2005-05-09 2006-11-16 Levin Bruce H Methods of alleviating disorders and their associated pain
WO2007025249A2 (en) * 2005-08-26 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administration of oxytocin
JP5129752B2 (ja) * 2005-11-18 2013-01-30 メルク・シャープ・エンド・ドーム・コーポレイション スピロヒダントイン三環式ｃｇｒｐ受容体アンタゴニスト
US20090312435A1 (en) * 2006-08-30 2009-12-17 Auspex Pharmaceuticals, Inc Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Similar Documents

Publication Publication Date Title
JP2013515002A5 (cg-RX-API-DMAC7.html)
US11690914B2 (en) Methods for photodynamic therapy
JP6434104B2 (ja) ジクロフェナク製剤
JP2010521442A (ja) 局所製剤処方
ES2714550T3 (es) Composiciones farmacéuticas y método para tratar la inflamación en ganado bovino y otros animales
JP6224115B2 (ja) 騒音嫌悪を軽減する獣医学的方法
JP2000143540A (ja) 非ステロイド系消炎鎮痛薬含有外用剤
ES2624557T3 (es) Composiciones farmacéuticas transdérmicas que comprenden un SERM
MXPA04007214A (es) Formulaciones topicas que contienen farmacos antiinflamatorios no esteroidales que demuestran actividad quimiopreventiva.
CA2583876A1 (en) A transmucosal veterinary composition comprising detomidine
ES2533854T3 (es) Composiciones farmacéuticas transdérmicas que comprenden danazol
RU2005132004A (ru) Стабилизированные композиции для местного применения, содержащие кетопрофен
US20130197089A1 (en) Compositions for the treatment of actinic keratosis
US20130190715A1 (en) Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis
JP2003119119A (ja) 肛門用の皮膚外用剤
US11642328B2 (en) Creatine, its derivatives, compositions and methods of use thereof
ES2963708T3 (es) Bromhexina para el tratamiento del dolor
JPS6127920A (ja) 消炎鎮痛性外用医薬組成物
JP2005089345A (ja) 虫刺され治療薬
KR20030027100A (ko) 화상의 치료
TR2024002454A1 (tr) Topical compositions comprising nimesulide and diclofenac sodium and a salicylate
JP2012067057A (ja) ピタバスタチン及びセルレニンを含有する経皮吸収促進剤
JP2023553300A (ja) フルニキシンを口腔投与することによる疼痛の治療方法
JP2012067055A (ja) セルレニンを含有する経皮吸収促進剤
JP2012067052A (ja) ピタバスタチンを含有する経皮吸収促進剤